CORR Insights®: What Proportion of Patients With Musculoskeletal Tumors Demonstrate Thromboelastographic Markers of Hypercoagulability? A Pilot Study : Clinical Orthopaedics and Related Research®

Secondary Logo

Journal Logo

SELECTED PROCEEDINGS FROM THE 2021 MUSCULOSKELETAL TUMOR SOCIETY MEETING GUEST EDITOR H. THOMAS TEMPLE MD

CORR Insights®: What Proportion of Patients With Musculoskeletal Tumors Demonstrate Thromboelastographic Markers of Hypercoagulability? A Pilot Study

Tsuda, Yusuke MD, PhD1

Author Information
Clinical Orthopaedics and Related Research 481(3):p 562-563, March 2023. | DOI: 10.1097/CORR.0000000000002372
© 2022 by the Association of Bone and Joint Surgeons

Full Text Access for Subscribers:

You can read the full text of this article if you:

Access through Ovid